Cited by 4,051Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. C., Montesi, M. P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. J., Wasco, W., Da Silva, H. A. R., Haines, J. L., Pericak-Vance, M. A., Tanzi, R. E., Roses, A. D., Fraser, P. E., Rommens, J. M., St George-Hyslop, P. H.·1995·Nature

DOI 10.1038/375754a0

Open this paper in CoChat — free account

Abstract

Some cases of Alzheimer's disease are inherited as an autosomal dominant trait. Genetic linkage studies have mapped a locus (AD3) associated with susceptibility to a very aggressive form of Alzheimer's disease to chromosome 14q24.3. We have defined a minimal cosegregating region containing the AD3 gene, and isolated at least 19 different transcripts encoded within this region. One of these transcripts (S182) corresponds to a novel gene whose product is predicted to contain multiple transmembrane domains and resembles an integral membrane protein. Five different missense mutations have been found that cosegregate with early-onset familial Alzheimer's disease. Because these changes occurred in conserved domains of this gene, and are not present in normal controls, they are likely to be causative of AD3.

Integrity signals

Registry

Crossref · 10.1038/375754a0

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,927
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citation
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Self-citation
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Self-citation
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Self-citation
The 1993–94 Généthon human genetic linkage map
Gyapay, G., Morissette, J., Alain Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M. G., & Weissenbach, J. (1994) · Nature Genetics · doi:10.1038/ng0694supp-246 · Cited by 1,835
Structural features in eukaryotic mRNAs that modulate the initiation of translation.
Kozak, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54860-2 · Cited by 1,826
A second-generation linkage map of the human genome
Weissenbach, J., Gyapay, G., Dib, C., Alain Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G., & Lathrop, M. G. (1992) · Nature · doi:10.1038/359794a0 · Cited by 1,672

Show all 48 references

Research works printed but not linked: 8

Foncin, J.-F. et al. Rev. Neurol. 141, 194–202 (1985).
Bergamini, L. et al. Acta neurol. 13, 534–538 (1991).
Cruts, M. et al. Neurobiol Aging 15, S129 (1994).
Saleeba, J. A. & Cotton, R. G. Meth. Enzym. 217, 285–295 (1993).
Liu, Q. & Sommer, S. S. BioTechniques 18, 470–476 (1995).
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. molec. Biol. 215, 403–410 (1990). · DOI · Paper page
Schellenberg, G. D. et al. Am. J. hum. Genet. 53, 619–628 (1993).
Kosik, K. & Greenberg, S. M. in Alzheimer Disease (eds Terry, R. D., Katzman, R. & Bick, K. L.) 335–344 (Raven, New York, 1994).

Sorted by citations

Items 801–900 of 1,049

Genetics of Alzheimer disease in the pre- and post-GWAS era
Ertekin‐Taner, N. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt26 · Cited by 112
Familial Alzheimer’s Disease Mutations in Presenilin Generate Amyloidogenic Aβ Peptide Seeds
Veugelen, S., Saito, T., Saido, T. C., Chávez‐Gutiérrez, L., & Strooper, B. D. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.010 · Cited by 107
Physical Exercise and Alzheimer’s Disease: Effects on Pathophysiological Molecular Pathways of the Disease
López‐Ortiz, S., Pinto-Fraga, J., Valenzuela, P. L., Martín-Hernández, J., Seisdedos, M. M., García, Ó., Toschi, N., Giuliano, F. D., Garaci, F. G., Mercuri, N. B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062897 · Cited by 107
Tmp21 and p24A, Two Type I Proteins Enriched in Pancreatic Microsomal Membranes, Are Members of a Protein Family Involved in Vesicular Trafficking
Blum, R., Feick, P., Puype, M., Vandekerckhove, J. S., Klengel, R., Nastainczyk, W., & Schulz, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17183 · Cited by 107
Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing
Bolino, A. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.1051 · Cited by 107
Generation of Anti-apoptotic Presenilin-2 Polypeptides by Alternative Transcription, Proteolysis, and Caspase-3 Cleavage
Vito, P., Ghayur, T., & D'adamio, L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28315 · Cited by 107
Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C
Walter, J., Grünberg, J., Capell, A., Pesold, B., Schindzielorz, A., Citron, M., Mendla, K. D., George‐Hyslop, P. S., Multhaup, G., Selkoe, D. J., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5349 · Cited by 107
Regulatory SNPs in complex diseases: their identification and functional validation
Prokunina‐Olsson, L., & Alarcón-Riquelme, M. E. (2004) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399404007690 · Cited by 108
A Founder Mutation in Presenilin 1 Causing Early-Onset Alzheimer Disease in Unrelated Caribbean Hispanic Families
Athan, E. S. (2001) · JAMA · doi:10.1001/jama.286.18.2257 · Cited by 107
C Terminus of Presenilin Is Required for Overproduction of Amyloidogenic Aβ42 through Stabilization and Endoproteolysis of Presenilin
Tomita, T., Takikawa, R., Koyama, A., Morohashi, Y., Takasugi, N., Saido, T. C., Maruyama, K., & Iwatsubo, T. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10627.1999 · Cited by 106
Interaction of Alzheimer's Presenilin-1 and Presenilin-2 with Bcl-XL
Passer, B. J., Pellegrini, L., Vito, P., Ganjei, J. K., & D'adamio, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24007 · Cited by 107
Presenilins Interact with Armadillo Proteins Including Neural‐Specific Plakophilin‐Related Protein and β‐Catenin
Lévesque, G., Yu, G., Nishimura, M., Zhang, D. M., Lévesque, L., Yu, W. H., Xu, D., Liang, Y., Rogaeva, E. A., Ikeda, M., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720999.x · Cited by 106
Self-citation
Drosophila models of human neurodegenerative disease
Chan, H. Y. E., & Bonini, N. M. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400757 · Cited by 105
The genetics of neuropsychiatric disorders
Bray, N. J., & O’Donovan, M. C. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818799271 · Cited by 113
Presenilins Mediate Phosphatidylinositol 3-Kinase/AKT and ERK Activation via Select Signaling Receptors
Kang, D. E., Yoon, I., Repetto, E., Busse, T., Yermian, N., Ie, L., & Koo, E. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500833200 · Cited by 107
Inhibition of ??-Secretase as a Therapeutic Intervention for Alzheimer???s Disease
Evin, G. M., Sernee, M. F., & Masters, C. L. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00002 · Cited by 106
APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome
Lai, F., Kammann, Η., Rebeck, G. W., Anderson, A. J., Chen, Y., & Nixon, R. A. (1999) · Neurology · doi:10.1212/wnl.53.2.331 · Cited by 105
APP Function and Lipids: A Bidirectional Link
Grimm, M. O. W., Mett, J., Grimm, H. S., & Hartmann, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00063 · Cited by 104
Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum
Ríos, J. A., Cisternas, P., Arrese, M. A., Salesa Barja, Y., & Inestrosa, N. C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.07.004 · Cited by 107
The Tottori (D7N) and English (H6R) Familial Alzheimer Disease Mutations Accelerate Aβ Fibril Formation without Increasing Protofibril Formation
Hori, Y., Hashimoto, T., Wakutani, Y., Urakami, K., Nakashima, K., Condron, M. M., Tsubuki, S., Saido, T. C., Teplow, D. B., & Iwatsubo, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608220200 · Cited by 107
Calcium paradox disease: Calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload
Fujita, T., & Palmieri, G. M. A. (2000) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740050101 · Cited by 104
Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval
Rademakers, R., Cruts, M., Dermaut, B., Sleegers, K., Rosso, S. M., den Broeck, M. V., Backhovens, H., Swieten, J. C. V., van Duijn, C. M., & Broeckhoven, C. V. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001198 · Cited by 105
The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta 42(43)
Kosaka, T., Imagawa, M., Seki, K., Arai, H., Sasaki, H., Tsuji, S., Asami-Odaka, A., Fukushima, T., Imai, K., & Iwatsubo, T. (1997) · Neurology · doi:10.1212/wnl.48.3.741 · Cited by 104
Ordered-Subsets Linkage Analysis Detects Novel Alzheimer Disease Loci on Chromosomes 2q34 and 15q22
Scott, W. K., Hauser, E. R., Schmechel, D. E., Welsh-Bohmer, K. A., Small, G. W., Roses, A. D., Saunders, A. M., Gilbert, J. R., Vance, J. M., Haines, J. L., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/379083 · Cited by 105
Self-citation
Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort
Jin, S. C., Pástor, P., Cooper, B., Cervantes, S., Benítez, B. A., Razquín, C., Goate, A., Ibero-American Alzheimer Disease Genetics Group Researchers, & Cruchaga, C. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt137 · Cited by 106
Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management
Siddiqi, K. S., Husen, A., Sohrab, S. S., & Yassin, M. O. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2638-7 · Cited by 104
Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes
Kurt, M. A. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00084-6 · Cited by 103
Genetics, Transcriptomics, and Proteomics of Alzheimers Disease
Papassotiropoulos, A., Fountoulakis, M., Dunckley, T. L., Stephan, D. A., & Reiman, E. M. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0418 · Cited by 105
Mechanisms of neuronal death in disease: defining the models and the players
Ribé, E. M., Serrano‐Saiz, E., Akpan, N., & Troy, C. M. (2008) · Biochemical Journal · doi:10.1042/bj20081118 · Cited by 107
Alzheimer’s Disease and Cancer: When Two Monsters Cannot Be Together
Majd, S., Power, J., & Majd, Z. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00155 · Cited by 102
Nature, nurture and neurology: gene–environment interactions in neurodegenerative disease
Spires‐Jones, T. L., & Hannan, A. J. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04677.x · Cited by 102
Overexpression in Neurons of Human Presenilin-1 or a Presenilin-1 Familial Alzheimer Disease Mutant Does Not Enhance Apoptosis
Bursztajn, S., DeSouza, R., McPhie, D. L., Berman, S. A., Shioi, J., Robakis, N. K. R. K., & Neve, R. L. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09790.1998 · Cited by 102
Epidemiology of the dementias: recent developments and new approaches.
van Duijn, C. M. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.5.478 · Cited by 102
Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-Protein
Citron, M., Eckman, C. B., Diehl, T. S., Corcoran, C., Ostaszewski, B. L., Xia, W., Levesque, G., St. George Hyslop, P., Younkin, S. G., & Selkoe, D. J. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0183 · Cited by 101
Increased Aβ42(43) from cell lines expressing presenilin 1 mutations
Mehta, N. D., Refolo, L. M., Eckman, C., Sanders, S., Yager, D., Perez‐Tur, J., Younkin, S., Duff, K., Hardy, J., & Hutton, M. (1998) · Annals of Neurology · doi:10.1002/ana.410430217 · Cited by 101
Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways
Duggan, S. P., & McCarthy, J. V. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.10.006 · Cited by 107
The zebrafish as a model for human disease
William, T. (2002) · Frontiers in bioscience · doi:10.2741/penber · Cited by 101
Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the β-amyloid peptide intracellularly in hippocampal and cortical neurons
Echeverrı́a, V., Ducatenzeiler, A., Dowd, E., Jänne, J., Grant, S. M., Szyf, M., Wandosell, F. G., Ávila, J., Grimm, H. S., Dunnett, S. B., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.036 · Cited by 104
Autophagy in Neurodegenerative Diseases and Metal Neurotoxicity
Zhang, Z., Miah, M. R., Culbreth, M. E., & Aschner, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1844-x · Cited by 101
Genetic Factors in the Genesis of Alzheimer's Disease
George‐Hyslop, P. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05552.x · Cited by 102
Presenilin structure, function and role in Alzheimer disease
Fraser, P. E., Yang, D.-S., Yu, G., Lévesque, L., Nishimura, M., Arawaka, S., Serpell, L. C., Rogaeva, E. A., & George‐Hyslop, P. S. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00028-4 · Cited by 103
Self-citation
Transgenic mouse models of Alzheimer’s disease
Janus, C., Chishti, M. A., & Westaway, D. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00033-8 · Cited by 101
Alternate Aggregation Pathways of the Alzheimer β-Amyloid Peptide: Aβ Association Kinetics at Endosomal pH
Gorman, P. M., Yip, C. M., Fraser, P. E., & Chakrabartty, A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01279-2 · Cited by 100
Self-citation
Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer's disease?
Li, X., & Buxbaum, J. N. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-79 · Cited by 104
Apolipoprotein E4 Stimulates cAMP Response Element-binding Protein Transcriptional Activity through the Extracellular Signal-regulated Kinase Pathway
Ohkubo, N., Mitsuda, N., Tamatani, M., Yamaguchi, A., Lee, Y., Ogihara, T., Vitek, M. P., & Tohyama, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005070200 · Cited by 100
Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives
Farrer, L. A., Cupples, L. A., van Duijn, C. M., Kurz, A., Zimmer, R., Müller, U., Green, R. C., Clarke, V., Shoffner, J. M., Wallace, D. C., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380515 · Cited by 100
Self-citation
The role of large pedigrees in an era of high-throughput sequencing
Wijsman, E. M. (2012) · Human Genetics · doi:10.1007/s00439-012-1190-2 · Cited by 99
Controlling the Regional Identity of hPSC-Derived Neurons to Uncover Neuronal Subtype Specificity of Neurological Disease Phenotypes
Imaizumi, K., Sone, T., Ibata, K., Fujimori, K., Yuzaki, M., Akamatsu, W., & Okano, H. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.005 · Cited by 101
Stress as risk factor for Alzheimer’s disease
Caruso, A., Nicoletti, F., Mango, D., Saidi, A., Orlando, R., & Scaccianoce, S. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.017 · Cited by 101
Genes and the Environment in Neurodegeneration
Coppedè, F., Mancuso, M., Siciliano, G., Migliore, L., & Murri, L. (2006) · Bioscience Reports · doi:10.1007/s10540-006-9028-6 · Cited by 100
Genome-wide association studies: the key to unlocking neurodegeneration?
Gandhi, S., & Wood, N. W. (2010) · Nature Neuroscience · doi:10.1038/nn.2584 · Cited by 101
The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease
Antúnez, C., Boada, M., González‐Pérez, A., Gayán, J., Ramírez‐Lorca, R., Marín, J., Hernández, I., Moreno‐Rey, C., Morón, F. J., López‐Arrieta, J., et al. (2011) · Genome Medicine · doi:10.1186/gm249 · Cited by 100
A Turning Point in Schizophrenia Genetics
Karayiorgou, M., & Gogos, J. A. (1997) · Neuron · doi:10.1016/s0896-6273(00)80390-6 · Cited by 99
Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport
Dumanchin, C. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1263 · Cited by 99
Neurodegeneration: diseases of the cytoskeleton?
McMurray, C. T. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400764 · Cited by 99
Synaptic plasticity in Alzheimer’s disease and healthy aging
Torres, D. M. C., & Cárdenas, F. P. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0058 · Cited by 101
Role of the Low-density Lipoprotein Receptor–Related Protein in β-Amyloid Metabolism and Alzheimer Disease
Hyman, B. T., Strickland, D. K., & Rebeck, G. W. (2000) · Archives of Neurology · doi:10.1001/archneur.57.5.646 · Cited by 98
Tetraspanin 6: a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments
Guix, F. X., Sannerud, R., Berditchevski, F., Arranz, A. M., Horré, K., Snellinx, A., Thathiah, A., Saido, T. C., Saito, T., Rajesh, S., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0165-0 · Cited by 103
Presenilins and Alzheimer's disease
Kim, T.-W., & Tanzi, R. E. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80089-x · Cited by 97
Self-citation
Inhibition of γ-secretase activity reduces Aβ production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease
Sheng, B., Gong, K., Niu, Y., Liu, L., Yan, Y., Lu, G., Zhang, L., Hu, M., Zhao, N., Zhang, X., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.018 · Cited by 98
Modulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies
Martinelli, A. H. S., Lopes, F. C., John, E. B. D. O., Carlini, C. R., & Ligabue‐Braun, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061322 · Cited by 99
Ca 2+ homeostasis dysregulation in Alzheimer's disease: a focus on plasma membrane and cell organelles
Wang, X., & Zheng, W. (2019) · The FASEB Journal · doi:10.1096/fj.201801751r · Cited by 97
Alzheimer’s disease: A clinical perspective and future nonhuman primate research opportunities
Haque, R. U., & Levey, A. I. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912954116 · Cited by 99
APP Family Regulates Neuronal Excitability and Synaptic Plasticity but Not Neuronal Survival
Lee, S. H., Kang, J., Ho, A., Watanabe, H., Bolshakov, V. Y., & Shen, J. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.011 · Cited by 97
The JNK/c-Jun cascade and Alzheimer's disease
Okazawa, H., & Estus, S. (2002) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750201700209 · Cited by 98
The amyloid‐β peptide and its role in Alzheimer's disease
Clippingdale, A. B., Wade, J. D., & Barrow, C. J. (2001) · Journal of Peptide Science · doi:10.1002/psc.324 · Cited by 103
Invertebrate models of Alzheimer's disease
Link, C. D. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2004.00105.x · Cited by 99
Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease
Taddei, K., Clarnette, R., Gandy, S., & Martins, R. N. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13394-8 · Cited by 98
Genetic variants in a haplotype block spanningIDE are significantly associated with plasma A?42 levels and risk for Alzheimer disease
Ertekin‐Taner, N., Allen, M., Fadale, D. J., Scanlin, L., Younkin, L. H., Petersen, R. C., Graff‐Radford, N. R., & Younkin, S. G. (2004) · Human Mutation · doi:10.1002/humu.20016 · Cited by 99
Genome-wide linkage disequilibrium mapping of late-onset Alzheimer’s disease in Finland
Hiltunen, M. O., Mannermaa, A., Thompson, D., Easton, D. F., Pirskanen, M. M., Helisalmi, S., Koivisto, A. M., Lehtovirta, M., Ryynänen, M., & Soininen, H. S. (2001) · Neurology · doi:10.1212/wnl.57.9.1663 · Cited by 97
A Genome Survey for Novel Alzheimer Disease Risk Loci: Results at 10-cM Resolution
Zubenko, G. S., Hughes, H. B., Stiffler, J. S., Hurtt, M. R., & Kaplan, B. B. (1998) · Genomics · doi:10.1006/geno.1998.5306 · Cited by 97
Multiple cellular and molecular mechanisms Are involved in human Aβ clearance by transplanted adult astrocytes
Pihlaja, R., Koistinaho, J., Kauppinen, R., Sandholm, J., Tanila, H., & Koistinaho, M. (2011) · Glia · doi:10.1002/glia.21212 · Cited by 96
Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
Dominantly Inherited Alzheimer Network, Ringman, J. M., Goate, A., Masters, C. L., Cairns, N. J., Danek, A., Graff-Radford, N., Ghetti, B., & Morris, J. C. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0499-8 · Cited by 96
Variant Alzheimer’s disease with spastic paraparesis
Verkkoniemi, A., Somer, M., Rinne, J. O., Myllykangas, L., Crook, R., Hardy, J., Viitanen, M. H., Kalimo, H., & Haltia, M. (2000) · Neurology · doi:10.1212/wnl.54.5.1103 · Cited by 96
Structure of β-amyloid fibrils and its relevance to their neurotoxicity: Implications for the pathogenesis of Alzheimer’s disease
Irie, K., Murakami, K., Masuda, Y., Morimoto, A., Ohigashi, H., Ohashi, R., Takegoshi, K., Nagao, M., Shimizu, T., & Shirasawa, T. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.99.437 · Cited by 104
Seladin-1 transcription is linked to neuronal degeneration in Alzheimer’s disease
Iivonen, S., Hiltunen, M., Alafuzoff, I. I., Mannermaa, A., Kerokoski, P., Puoliväli, J. T., Salminen, A., Helisalmi, S., & Soininen, H. S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00180-x · Cited by 97
Biomarker-based dissection of neurodegenerative diseases
Olsson, B., Zetterberg, H., Hampel, H. J., & Blennow, K. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.04.006 · Cited by 102
Genetics of Alzheimer’s Disease
Ridge, P. G., Ebbert, M., & Kauwe, J. S. K. (2013) · BioMed Research International · doi:10.1155/2013/254954 · Cited by 104
Characterization of VPS41 , a gene required for vacuolar trafficking and high-affinity iron transport in yeast
Radisky, D. C., Snyder, W. B., Emr, S. D., & Kaplan, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5662 · Cited by 96
Genetic variation in a haplotype block spanningIDE influences Alzheimer disease
Prince, J. A., Feuk, L., Gu, H. F., Johansson, B. E. A., Gatz, M., Blennow, K., & Brookes, A. J. (2003) · Human Mutation · doi:10.1002/humu.10282 · Cited by 96
Self-citation
Presenilin-1 polymorphism and Alzheimer's disease
Owen, M. J., Kehoe, P. G., & Williams, J. H. (1996) · The Lancet · doi:10.1016/s0140-6736(05)65041-6 · Cited by 96
Wnt/β-Catenin Signaling in Alzheimer’s Disease
Ferrari, G., Avila, M., Medina, M., Perez-Palma, E., Bustos, B., & Alarcon, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527312666131223113900 · Cited by 95
Is Alzheimer's Disease a Disorder of Mitochondria-Associated Membranes?
Schon, E. A., & Área-Gómez, E. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100495 · Cited by 98
Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis
Supnet, C. B., & Борисович, Б. И. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.05.013 · Cited by 95
Alzheimer's Disease and the Eye☆
Armstrong, R. A. (2009) · Journal of Optometry · doi:10.3921/joptom.2009.103 · Cited by 101
Aluminum Should Now Be Considered a Primary Etiological Factor in Alzheimer’s Disease
Exley, C. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170010 · Cited by 95
Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2.
Wijsman, E. M., Daw, E. W., Yu, C.-E., Payami, H., Steinbart, E. J., Nochlin, D., Conlon, E. M., Bird, T. D., & Schellenberg, G. D. (2004) · The American Journal of Human Genetics · doi:10.1086/423393 · Cited by 71
Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid β
Uematsu, M., Nakamura, A., Ebashi, M., Hirokawa, K., Takahashi, R., & Uchihara, T. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0501-1 · Cited by 96
Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases
de Souza, J. M., Gonçalves, B. D. C., Gomez, M. V., Vieira, L. B., & Ribeiro, F. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00145 · Cited by 94
The Solved and Unsolved Mysteries of the Genetics of Early-Onset Alzheimer 's Disease
Rogaeva, E. A. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:1:01 · Cited by 96
Self-citation
The presenilin protein family member SPE-4 localizes to an ER/Golgi derived organelle and is required for proper cytoplasmic partitioning during Caenorhabditis elegans spermatogenesis
Arduengo, P. M., Appleberry, O. K., Chuang, P., & L’Hernault, S. W. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.24.3645 · Cited by 97
Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation
Rossor, M. N., Fox, N. C., Beck, J. A., Campbell, T., & Collinge, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90715-1 · Cited by 94
Association Between Angiotensin-Converting Enzyme and Alzheimer Disease
Farrer, L. A., Sherbatich, T., Keryanov, S. A., Коровайцева, Г. И., Rogaeva, E. A., Petruk, S., Premkumar, S., Moliaka, Y., Song, Y., Pei, Y., et al. (2000) · Archives of Neurology · doi:10.1001/archneur.57.2.210 · Cited by 94
Self-citation
Familial Alzheimer’s Disease Mutations Differentially Alter Amyloid β-Protein Oligomerization
Gessel, M. M., Bernstein, S. L., Kemper, M., Teplow, D. B., & Bowers, M. T. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300050d · Cited by 97
EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease
Пономарева, Н. В., Коровайцева, Г. И., & Rogaev, E. I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.019 · Cited by 96
Self-citation
LIN-12/Notch signaling in C. elegans
Greenwald, I. (2005) · WormBook · doi:10.1895/wormbook.1.10.1 · Cited by 93
Brain-derived neurotrophic factor gene polymorphisms and Alzheimer?s disease
Matsushita, S., Arai, H., Matsui, T., Yuzuriha, T., Urakami, K., Masaki, T., & Higuchi, S. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0210-3 · Cited by 93
Increased expression of the γ‐secretase components presenilin‐1 and nicastrin in activated astrocytes and microglia following traumatic brain injury
Nadler, Y., Alexandrovich, A. G., Grigoriadis, N., Hartmann, T., Rao, K. S. J., Shohami, E., & Stein, R. (2008) · Glia · doi:10.1002/glia.20638 · Cited by 97
Aberrant Splicing in the Presenilin-1 Intron 4 Mutation Causes Presenile Alzheimer's Disease by Increased A 42 Secretion
Jonghe, C. D., MarcCruts, Rogaeva, E. A., Tysoe, C. J., Singleton, A., Vanderstichele, H., Meschino, W. S., Dermaut, B., Vanderhoeven, I., Backhovens, H., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1529 · Cited by 95
Self-citation
Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer’s disease mouse models
Neuner, S. M., Wilmott, L. A., Hoffmann, B. R., Mozhui, K., & Kaczorowski, C. C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.002 · Cited by 95

Authors: Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. C., Montesi, M. P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. J., Wasco, W., Da Silva, H. A. R., Haines, J. L., Pericak-Vance, M. A., Tanzi, R. E., Roses, A. D., Fraser, P. E., Rommens, J. M., & St George-Hyslop, P. H.
Affiliations: University of Toronto (CA)
Inserm (FR)
University of Florence (IT)
University of Turin (IT)
National Institutes of Health (US)
Fondation Jean Dausset-CEPH (FR)
University of Massachusetts Chan Medical School (US)
Western General Hospital (GB)
Sandoz Group AG (Switzerland) (CH)
Harvard University (US)
Duke University (US)
ORCID: Rogaev, E. I.
Liang, Y.
Rogaeva, E. A.
Ikeda, M.
Lin, C.
Tsuda, T.
Bruni, A. C.
Sorbi, S.
Rainero, I.
Pinessi, L.
Brookes, A.
Haines, J. L.
Tanzi, R. E.
Rommens, J. M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1995-06
Volume: 375
Issue: 6534
Pages: 754-760
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/375754a0
OpenAlex: W2046209489
Cited by: 4,051
References: 48
Citations by year: 2026: 36 · 2025: 70 · 2024: 78 · 2023: 54 · 2022: 93 · 2021: 93 · 2020: 118 · 2019: 107 · 2018: 105 · 2017: 116 · 2016: 140 · 2015: 100 · 2014: 132 · 2013: 120 · 2012: 134
FWCI: 144.01
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Florence Research (University of Florence) (submittedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Funders: Canadian Institutes of Health Research (64309)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: early-onset familial Alzheimer's disease, missense mutations, autosomal dominant inheritance, gene cloning, co-segregation, transmembrane proteins, novel genes, susceptibility genes
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Animals, Base Sequence, Chromosome Mapping, Chromosomes, Human, Pair 14, Cloning, Molecular, Female, Humans, Male, Membrane Proteins, Molecular Sequence Data, Mutation, Pedigree, Transcription, Genetic, Open Reading Frames, Protein Structure, Secondary, Mice, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks